MMIS Chosen by CIO Review as Top 20 Most Promising Pharma and Life Science Technology Solution Providers 2015

Share Article

MediSpend Global Platform Recognized as Top-Notch Solution

Fremont, CA (PRWEB)April 17, 2015

CIO Review (http://www.cioreview.com) has chosen MMIS (http://www.medispend.com) for its 20 Most Promising Pharma and Life Science Technology Solution Providers 2015. The positioning is based on MMIS’s MediSpend global compliance software platform for life sciences companies.

The annual list of companies is selected by a panel of experts and members of CIO Review’s editorial board to recognize and promote technology entrepreneurship. “MMIS’s MediSpend Platform has been on our radar for some time now for stirring a revolution in the pharma and life science space, and we are happy to showcase them this year due to their continuing excellence in delivering top-notch solutions,” said Harvi Sachar, Publisher and Founder, CIO Review. “MMIS’s solutions continued to break new ground within the past year benefiting its customers around the globe, and we’re excited to have them featured on our top companies list.”

“We are honored to be recognized by CIO Review’s panel of experts and thought leaders,” said Michaeline Daboul, CEO, MMIS.

About MMIS
MMIS is a global technology company providing compliance and business intelligence solutions for the life sciences industry. Developed by a team of experienced attorneys and IT specialists, the MediSpend Global Compliance Platform represents the first end-to-end compliance and data analytics SaaS solution designed specifically to help life science executives make better-informed business decisions while ensuring compliance with global transparency laws.

About CIO Review
CIO Review constantly endeavors to identify "The Best" in a variety of areas important to tech business. Through nominations and consultations with industry leaders, our editors choose the best in different domains. Pharma and Life Science Special edition is an annual listing of 20 Most Promising Pharma and Life Science Technology Solution Providers in the U.S.